Expression of Bax and Bcl-2 in tumour cells and blood vessels of breast cancer and their association with angiogenesis and hormonal receptors

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 8, 2012, Pages 3857-3862

  Jaafar, Hasnan ^a   Abdullah, Suhaila ^a   Murtey, Mogana Das ^a   Idris, Fauziah M ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

Author keywords

Angiogenesis; Apoptosis; Blood vessels; Breast cancer cells; Hormonal receptors

Indexed keywords

EID: 84873650167     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.8.3857     Document Type: Article

References (49)

1. Affara MB, Dunmore C, Savoie S, et al. (2007). Understanding endothelial cell apoptosis:what can the transcriptome, glycome and proteome reveal? Phil Trans R Soc B, 362 1469-87.
2. Allred DC, Harvey JM, Berardo M, Clark GM. (1998). Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol, 11, 155-68.
3. Al-Maoundhri M, Nirmala V, Al-Mawaly K, et al. (2003). Significance of p53, Bcl-2, and HER-2/neu protein expression in Omani Arab females with breast cancer, Pathol Oncol Res, 9, 226-31.
4. Axelsson K, Ljung BM, Moore DH, et al. (1995). Tumor angiogenesis as a prognostic assay for invasive ductal breast carcinoma, J Natl Cancer Inst, 87, 997-1008.
5. Baccouche S, Daoud J, Frikha M, et al. (2003) Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients, Ann N Y Acad Sci, 1010, 752-63.
6. Carmeliet P, Dor Y, Herbert JM, et al. (1998). Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumor angiogenesis. Nature 394 485-490. Erratum in Nature, 395, 525.
7. Carmeliet P, Lampugnani MG, Moons L, et al. (1999). Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis. Cell, 98, 147-57.
8. DAKO HercepTestTM for Immunoenzymatic Staining. (1999) (Packge insert) DAKO A/S, Glastrup, Denmark.
9. Djonov V, Andres AC, Ziemiecki A. (2001). Vascular remodelling during the normal and malignant life cycle of the mammary gland. Microsc Res Tech, 52, 182-9.
10. Folkman J. (2003). Angiogenesis and apoptosis. Seminar Cancer Biol, 13, 159-67.
11. Frierson HF Jr, Wolber RA, Berean KW, et al. (1995). Interobserver reproducibility of the Notiingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol, 103, 195-8
12. Giorgadze TA, Baloch ZW, Pasha T, Zhang PJ, LiVolsi VA. (2005). Lymphatic and blood vessel density in the follicular patterned lesions of thyroid, Mod Pathol, 18, 1424-31.
13. Gompel A, Somai S, Chaout M. (2000). Hormonal regulation of apoptosis in breast cells and tissues, Steroids, 65, 593-8.
14. Hanahan D, Folkman J. (1996). Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-64.
15. Harada T, Kaponis A, Iwabe T, et al. (2004). Apoptosis in human endometrium and endometriosis. Hum Reprod Update 10 29-38.
16. Hasnan J, Yusof MI, Damitri TD, et al. (2010). Relationship between apoptotic markers (Bax and Bcl-2) and biochemical markers in type 2 diabetes mellitus. Singapore Med J, 51 50-5.
17. Holash J, Wiegand SJ, Yancopoulos GD. (1999). New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene, 18, 5356-62
18. Holmgren L, O'Reilly MS, Folkman J. (1995). Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med, 1, 149-53.
19. Intengan HD, Schiffrin EL. (2001). Vascular remodeling in hypertension: roles of apoptosis, inflammation, and fibrosis. Hypertension, 38, 581-7.
20. Jan-Show C, Chiun-Sheng H, King-jen C. (1998). The prognostic significance of tumor angiogenesis in Taiwanese patients with invasive ductal breast carcinomas, Cancer Letters, 134, 7-14.
21. Kahlos K, Soini Y, Pääkkö P, et al. (2000). Proliferation, apoptosis, and manganese superoxide dismutase in malignant mesothelioma. Int J Cancer, 88, 37-43.
22. Karelia NH, Patel DD, Balar DB, et al. (1997). Prognostic significance of tumor angiogenesis in advanced breast carcinoma: an Indian experience. Neoplasma, 44, 163-6.
23. Kebers F, Lewalle JM, Desreux J et al. (1998). Induction of endothelial cell apoptosis by solid tumor cells. Experimental Cell Res, 240, 197-205
24. Kerr JFR, Wyllie AH, Currie AR. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer, 26, 239-57
25. Kobayashi S, Iwase H, Ito Y, et al. (1997). Clinical significance of Bcl-2 gene expression in human breast cancer tissues, Breast Cancer Res Treat, 42, 173-81.
26. Krajewski S, Krajewska M, Turner BC, et al. (1999). Prognostic significance of apoptosis regulators in breast cancer, Endocr Relat Cancer, 6, 29-40.
27. Linjawi A, Kontogiannea M, Halwani F, Edwardes M, Meterissian S. (2004). Prognostic significance of p53, bcl-2, and Bax expression in early breast cancer. J Am Coll Surg, 198, 83-90.
28. Lipponen P. (1999). Apoptosis in breast cancer: relationship with other pathological parameters. Endocrine Related Cancer, 6, 13-6.
29. Maisonpierre PC, Suri C, Jones PF, Bartunkova S, et al. (1997). Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science, 277, 55-60.
30. Merja V, Kimmo L, Hannu R, Paavo P, Yiermi S. (1999). Apoptosis during breast carcinoma progression. Clin Cancer Res, 5, 319-24.
31. Nazan G, Zafer A, Ugur C, et al. (2002). Prognostic importance of tumor angiogenesis in breast carcinoma with adjuvant chemotherapy. Pathol Res Pract, 198, 7-12.
32. Perrone G, Vincenzi B, Santini D, et al. (2004). Correlation of 53 and bcl-2 expresion with vascular endothelial growth factor (VEGF), microvessel density (MVD) and clinicopathological features in colon cancer. Cancer Letters, 208, 227-34.
33. Qureshi A, Pervez S. (2010).Allred scoring for ER reporting and its impact in clearly distinguishing ER negative from ER positive breast cancers. J Pak Med Assoc, 60, 350-3.
34. Ray SK, Patel SJ, Welsh CT, et al. (2002). Molecular evidence of apoptotic death in malignant brain tumors including glioblastoma multiforme: upregulation of calpain and caspase-3. J Neurosci Res, 69, 197-206.
35. Rochaix P, Krajewski S, Reed JC, et al. (1999). In vivo patterns of Bcl-2 family protein expression in breast carcinoma in relation to apoptosis, J Pathol, 187, 410-5.
36. Sirvent JJ, Aguilar MC, Olona M, et al. (2004). Prognostic value of apoptosis in breast cancer (pT1-pT2). A TUNEL, p53, bcl-2, bag-1 and Bax immunohistochemical study. Histol Histopathol, 19, 759-70.
37. Soini Y, Paakko P, Lehto VP. (1998). Histopathological evaluation of apoptosis in cancer. Am J Pathol, 153, 1041-53.
38. Tenderenda M, Rutkowski P, Jesionek-Kupnicka D, Kubiak R. (2001). Expression of CD34 in gastric cancer and is correlation with histology grade, stage, proliferation activity, p53 expression and apoptotic index. Pathol Oncol Res, 7 129-34.
39. Thurston G, Suri C, Smith K, et al. (1999). Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science, 286, 2511-4.
40. Tjalma WA, Weyler JJ, Bogers JJ, et al. (2001). The importance of biological factors (bcl-2, bax, p53, PCNA, MI, HPV and angiogenesis) in invasive cervical cancer. Eur J Obstetrics Gynaecol Reprod Biol, 97, 223-30.
41. Vamesu S. (2008). Angiogenesis and tumor histologic type in primary breast cancer patients: an analysis of 155 needle core biopsies. Rom J Morphol Embryol, 49, 181-8.
42. Veronese S, Mauri FA, Caffo O, et al. (1998). Bax immunohistochemical expression in breast carcinoma: a study with long term follow-up. Int J Cancer, 79, 13-8.
43. Vogl G, Dietze O, Hauser-Kronberger C. (2005). Angiogenic potential of ductal carcinoma in situ (DCIS) of human breast, Histopathology, 47, 617-24.
44. Weidner N, Semple JP, Welch WR, Folkman J. (1991). Tumor angiogenesis and metastasis correlation in invasive breast carcinoma. N Engl J Med, 324, 1-8.
45. White E. (1996). Life, death, and the pursuit of apoptosis. A review. Genes Dev, 10, 1-15.
46. Yancopoulos GD, Davis S, Gale NW, et al. (2000). Vascular specific growth factors and blood vessel formation. Nature, 407, 242-8.
47. Yang X, Hao Y, Ding Z, Pater A, Tang SC. (1999). Differential expression of antiapoptotic gene BAG-1 in human breast normal and cancer cell lines and tissues. Clin Cancer Res 5. 1816-22.
48. Yu Q, Stamenkovic I. (2001). Angiopoietin-2 is implicated in the regulation of tumor angiogenesis. Am J Pathol, 158, 563-70.
49. Zheng L, Dengler TJ, Kluger MS, et al. (2000). Cytoprotection of human umbilical vein endothelial cells against apoptosis and CTL-mediated lysis provided by caspase-resistant Bcl-2 without alterations in growth or activation responses. J Immunol, 164, S4665-71.